Autosomally dominant sleep-related hypermotor epilepsy (ADSHE) is a form of epilepsy characterized by complex sleep-related seizures. Recent research suggests that nicotine, especially via transdermal patches, may improve seizure control in affected patients.
This study highlights the potential of personalized nicotine treatment, administered throughout the day and night, to enhance quality of life for individuals with this condition. It emphasizes the importance of tailored therapies based on genetic and clinical profiles.